Supplementary Table 3 from Synthetic Lethal Targeting of <i>ARID1A</i>-Mutant Ovarian Clear Cell Tumors with Dasatinib
Rowan E. Miller,Rachel Brough,Ilirjana Bajrami,Chris T. Williamson,Simon McDade,James Campbell,Asha Kigozi,Rumana Rafiq,Helen Pemberton,Rachel Natrajan,Josephine Joel,Holly Astley,Claire Mahoney,Jonathan D. Moore,Chris Torrance,John D. Gordan,James T. Webber,Rebecca S. Levin,Kevan M. Shokat,Sourav Bandyopadhyay,Christopher J. Lord,Alan Ashworth crossref(2023)
摘要
Additional compounds included in the isogenic high-throughput drug screen
更多查看译文
AI 理解论文
溯源树
样例